Moderators:
Search This Board: 
Created: 11/30/2005 08:26:34 AM - Followers: 124 - Board type: Free - Posts Today: 1








BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The Company holds the rights to clinical development and commercialization of the NurOwn technology platform used to produce autologous MSC-NTF cells through an exclusive, worldwide licensing agreement. Autologous MSC-NTF cells have received Orphan Drug status designation from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm has fully enrolled a Phase 3 pivotal trial in ALS (NCT03280056), investigating repeat-administration of autologous MSC-NTF cells at six U.S. sites supported by a grant from the California Institute for Regenerative Medicine (CIRM CLIN2-0989). The pivotal study is intended to support a filing for U.S. FDA approval of autologous MSC-NTF cells in ALS. BrainStorm also recently received U.S. FDA clearance to initiate a Phase 2 open-label multicenter trial in progressive multiple sclerosis (MS). The Phase 2 study of autologous MSC-NTF cells in patients with progressive MS (NCT03799718) started enrollment in March 2019. 

Brainstorm Cell Therapeutics Inc.

1325 Avenue of Americas
28th Floor
New York, NY 10019
United States
201-488-0460
http://www.brainstorm-cell.com



 

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#3225
My guess is the BLA was filed around bubbarayjr 09/24/2022 08:27:27 AM
#3224
- I just saw this on the No Fmello 09/22/2022 10:08:09 AM
#3223
..... Fmello 09/17/2022 12:10:41 PM
#3222
NurOwn Found Safe, Shows Promise in Phase 2 Fmello 09/17/2022 12:08:33 AM
#3221
BrainStorm Brings MS Data on Heels of ALS Fmello 09/16/2022 11:40:14 PM
#3220
Maxim Group analyst Jason McCarthy maintained a Buy Fmello 09/16/2022 08:17:31 AM
#3219
BrainStorm Cell Therapeutics Announces Peer Reviewed Publication of midastouch017 09/15/2022 06:17:05 AM
#3218
BrainStorm Cell Therapeutics Announces Peer Reviewed Publication of Fmello 09/15/2022 06:17:00 AM
#3216
Wrong board, my friend! midastouch017 09/14/2022 05:00:48 PM
#3214
AMLX paves the way for BCLI: 10+ Bagger bubbarayjr 09/10/2022 08:15:51 AM
#3213
AMLX is up 77% in pre-market and as Fmello 09/08/2022 09:19:04 AM
#3212
I'm really curious to see what their stock Fmello 09/07/2022 09:18:03 PM
#3211
AMLX FDA 's Positive vote bodes very well bubbarayjr 09/07/2022 08:45:59 PM
#3210
AMLX passed the FDA committee vote 7 yes, Fmello 09/07/2022 07:53:08 PM
#3209
https://www.biospace.com/article/als-thought-leaders-weigh-in-ahead-of-second-am Fmello 09/07/2022 12:48:37 AM
#3208
No comparison intended, hence my midastouch017 09/05/2022 12:06:21 PM
#3207
Will be interesting to see how the committee bubbarayjr 09/05/2022 07:39:58 AM
#3206
FDA still skeptical of ALS drug ahead of midastouch017 09/04/2022 08:55:28 AM
#3205
FDA has 60 days to accept or decline bubbarayjr 09/04/2022 08:09:18 AM
#3204
https://www.youtube.com/watch?v=mqEWQvK7Uyg&ab_channel=U.S.FoodandDrugAdministra Fmello 08/31/2022 07:53:56 PM
#3203
Quote from Seeking Alpha. midastouch017 08/22/2022 12:19:16 AM
#3202
Here's the link: Fmello 08/21/2022 10:15:15 AM
#3201
Brainstorm Cell Therapeutics: Upcoming BLA In ALS midastouch017 08/21/2022 05:43:02 AM
#3200
BioSpace: NurOwn A Study in the complexity of bubbarayjr 08/20/2022 06:35:05 PM
#3199
ALS News: NurOwn bubbarayjr 08/20/2022 06:32:56 PM
#3198
I do hope the treatment will be approved, midastouch017 08/18/2022 11:59:37 PM
#3197
BCLI: Filing a BLA for NurOwn® for the Fmello 08/18/2022 03:07:24 PM
#3196
Brainstorm Cell Therapeutics (BCLI) Receives a Buy from Fmello 08/17/2022 11:30:38 AM
#3195
As of 11:08AM EDT. Market open. midastouch017 08/17/2022 11:09:35 AM
#3194
https://www.facebook.com/michelle.lorenz.395/videos/1028900704442247 Fmello 08/16/2022 08:28:55 PM
#3193
Might be the reason for the extra chatter Windbag1014 08/16/2022 01:05:45 PM
#3192
No More Excuses! ALS Watch Dog Group midastouch017 08/16/2022 11:44:02 AM
#3191
I don't have a Facebook account so can Fmello 08/16/2022 11:18:19 AM
#3190
Indeed, If the cash burn continues at current rate, midastouch017 08/16/2022 10:58:52 AM
#3189
The one thing that I'm wooried about: Fmello 08/16/2022 10:18:41 AM
#3188
I am pretty confident the stock will midastouch017 08/16/2022 09:32:49 AM
#3187
I guess the market decided it won’t get midastouch017 08/16/2022 01:01:15 AM
#3186
Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits Fmello 08/15/2022 06:54:53 PM
#3185
I guess the market decided it won’t get murocman 08/15/2022 05:33:06 PM
#3184
https://www.fiercebiotech.com/biotech/after-fda-slammed-breaks-brainstorm-therap Fmello 08/15/2022 04:52:41 PM
#3183
I'm confused about what happened to the stock Fmello 08/15/2022 04:30:02 PM
#3182
How long does it take the FDA to midastouch017 08/15/2022 09:34:44 AM
#3181
ABOUT FRIGGIN' TIME!!! Fmello 08/15/2022 09:01:51 AM
#3180
4.1700 +0.7000 (+20.1729%) midastouch017 08/15/2022 08:05:00 AM
#3179
BrainStorm to seek FDA approval for ALS therapy midastouch017 08/15/2022 07:54:24 AM
#3178
BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial midastouch017 08/15/2022 07:46:54 AM
#3177
Just a reminder that Brainstorm's 2nd quarter earnings Fmello 08/14/2022 10:27:50 PM
#3176
Monday is going to be very midastouch017 08/14/2022 10:13:11 AM
#3175
https://www.youtube.com/watch?v=ZKTLRUCo2Vc&ab_channel=ALSNewsNow%21 Fmello 08/13/2022 11:03:00 PM
#3174
https://www.linkedin.com/feed/update/urn:li:share:6964070853491777536?utm_source=linkedin_share& Fmello 08/13/2022 04:36:07 PM
Post Subject